Prevention of sacituzumab govitecan-related neutropenia and diarrhea in patients with HER2-negative advanced breast cancer (PRIMED): an open-label, single-arm, phase 2 trial

Colaboración

Año: 2025

Pérez-García, JM; Gion, M; Ruiz-Borrego, M; Blancas, I; López-Miranda, E; Blanch, S; Recalde, S; Rendo, CR; González, X; Ancizar, N; Morales, S; Cortez, P; Piwowarska, Z; Shimizu, E; Guerrero, JA; Sampayo-Cordero, M; Martínez-Bueno, A; Cortés, J; Llombart-Cussac, A

Título: ECLINICALMEDICINE

• D1